Tags: stem cells, stroke, fda
Thursday, January 22, 2009
Genetically engineered neural stem cells approved for stroke trial
ReNeuron has just received permission to launch a clinical trial for stroke patients using neural stem cells. About a dozen patients will receive the cells at Southern General Hospital in Glasgow, Scotland. An article in the Financial Times chronicles the path to obtain regulatory permission to launch the trial in the UK. An article in NatureNews describes how the cells, derived originally from aborted fetuses, have been genetically engineered with an inducible gene to control cells’ growth. The prospect of transplanting genetically engineered cells worried advisors to the FDA’s panel on starting clinical trials with embryonic stem cells last year, though Geron is still pressing ahead on this front.
Subscribe to:
Post Comments (Atom)
1 comment:
There is no doubt that medical science has achieved a number of mile stones, especially at the time of emergency but at the same time it is also true that its medication has a number of side effects. So at that moment stem cell therapy can be considered as a perfect solution that to without any medication. Thank you.Stem cell cure
Post a Comment